Intuitive Surgical, Inc. (NASDAQ:ISRG) Shares Purchased by Sycomore Asset Management

Sycomore Asset Management increased its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 63.0% during the third quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission (SEC). The firm owned 14,866 shares of the medical equipment provider’s stock after acquiring an additional 5,746 shares during the quarter. Sycomore Asset Management’s holdings in Intuitive Surgical were worth $7,230,000 as of its most recent SEC filing.

A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in the stock. Hazlett Burt & Watson Inc. lifted its holdings in Intuitive Surgical by 5.8% in the third quarter. Hazlett Burt & Watson Inc. now owns 362 shares of the medical equipment provider’s stock valued at $177,000 after acquiring an additional 20 shares during the period. Mitchell Mcleod Pugh & Williams Inc. grew its stake in Intuitive Surgical by 4.1% during the 3rd quarter. Mitchell Mcleod Pugh & Williams Inc. now owns 503 shares of the medical equipment provider’s stock valued at $247,000 after purchasing an additional 20 shares during the last quarter. Ullmann Wealth Partners Group LLC grew its stake in Intuitive Surgical by 1.6% during the 3rd quarter. Ullmann Wealth Partners Group LLC now owns 1,329 shares of the medical equipment provider’s stock valued at $653,000 after purchasing an additional 21 shares during the last quarter. One Wealth Management Investment & Advisory Services LLC boosted its stake in shares of Intuitive Surgical by 3.4% in the second quarter. One Wealth Management Investment & Advisory Services LLC now owns 697 shares of the medical equipment provider’s stock worth $310,000 after buying an additional 23 shares during the last quarter. Finally, Falcon Wealth Planning boosted its stake in shares of Intuitive Surgical by 0.4% in the third quarter. Falcon Wealth Planning now owns 5,693 shares of the medical equipment provider’s stock worth $2,797,000 after buying an additional 23 shares during the last quarter. 83.64% of the stock is owned by hedge funds and other institutional investors.

Insider Buying and Selling at Intuitive Surgical

In other news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction that occurred on Friday, August 23rd. The shares were sold at an average price of $486.84, for a total value of $19,591,902.12. Following the transaction, the senior vice president now owns 3,001 shares in the company, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. In other Intuitive Surgical news, SVP Henry L. Charlton sold 40,243 shares of the firm’s stock in a transaction on Friday, August 23rd. The stock was sold at an average price of $486.84, for a total transaction of $19,591,902.12. Following the completion of the transaction, the senior vice president now owns 3,001 shares of the company’s stock, valued at approximately $1,461,006.84. This trade represents a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Also, insider Jamie Samath sold 269 shares of the firm’s stock in a transaction on Monday, November 11th. The shares were sold at an average price of $539.89, for a total value of $145,230.41. Following the transaction, the insider now directly owns 8,757 shares of the company’s stock, valued at $4,727,816.73. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 91,178 shares of company stock worth $45,897,071 over the last ninety days. Insiders own 0.90% of the company’s stock.

Wall Street Analysts Forecast Growth

Several equities research analysts recently commented on ISRG shares. Piper Sandler reaffirmed an “overweight” rating and issued a $538.00 price target (up previously from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. Citigroup lifted their target price on Intuitive Surgical from $512.00 to $560.00 and gave the stock a “buy” rating in a research report on Thursday, August 22nd. JPMorgan Chase & Co. boosted their price target on Intuitive Surgical from $495.00 to $575.00 and gave the company an “overweight” rating in a research report on Friday, October 11th. Redburn Atlantic raised Intuitive Surgical from a “neutral” rating to a “buy” rating and lifted their price objective for the company from $380.00 to $510.00 in a report on Friday, August 2nd. Finally, Stifel Nicolaus upped their target price on Intuitive Surgical from $475.00 to $525.00 and gave the company a “buy” rating in a research note on Friday, October 18th. One investment analyst has rated the stock with a sell rating, five have given a hold rating and fourteen have issued a buy rating to the company. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $513.74.

Intuitive Surgical Price Performance

Shares of NASDAQ ISRG traded up $6.84 during trading on Thursday, hitting $543.53. The stock had a trading volume of 397,463 shares, compared to its average volume of 1,454,509. The company has a market capitalization of $193.59 billion, a PE ratio of 86.28, a PEG ratio of 5.28 and a beta of 1.39. The firm has a fifty day moving average of $496.95 and a two-hundred day moving average of $455.65. Intuitive Surgical, Inc. has a 12 month low of $291.39 and a 12 month high of $544.38.

Intuitive Surgical (NASDAQ:ISRG) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating the consensus estimate of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The business had revenue of $2.04 billion for the quarter, compared to the consensus estimate of $2.01 billion. On average, equities analysts expect that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current fiscal year.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.